2026 NPPES data Internal Medicine Physician NPI 1316054539 MD
Verify on CMS →

Kevork Boyadjian, MD

Internal Medicine Physician in Middle Village, New York.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 172,737 in Internal Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
8K
Medicare Part D claims · 475 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
82%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
96.4/100
▲ 13 pts above national avg 83.1 · Exceptional
Industry payments
$371.98
7 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Kevork Boyadjian, MD reported a CMS MIPS final score of 96.4/100 - above the 83.1 national average - and filed 8,337 Medicare Part D claims in 2023.

96.4/100
MIPS score · +13 vs avg
8K
Part D claims, 2023
82%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Kevork Boyadjian, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure

96 Top 17% higher than 83% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90+: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Kevork Boyadjian, MD sits

This provider among internal medicine physician peers

Across the 36,260 internal medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Kevork Boyadjian, MD writes more Part D claims than 89% of them and scores higher on MIPS quality than 84% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality02550751000255075100Part D claim volume, percentile in specialtyMIPS quality, percentile
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one internal medicine physician peer from a representative sample of 60; the gold marker is Kevork Boyadjian, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Kevork Boyadjian, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Kevork Boyadjian, MD?

High performer (top quartile)

NPI registry status

Active

Issued 08/24/2006

NPI 1316054539

Primary specialty

Internal Medicine Physician

High-volume

172,737 US NPIs in this specialty

Medicare Part D claims

8,337 207% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

MIPS final score

96.4/100 13.3 pts vs avg

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Internal Medicine Physician compares to other specialties among New York providers

New York providers
Student in an Organized Heal…7.8%Registered Nurse5.2%Clinical Social Worker4.9%Social Worker4.5%Speech-Language Pathologist4.5%Licensed Practical Nurse4.3%Internal Medicine Physician2.6%
Largest specialties in New York (% of in-state providers)

Medicare quality performance, MIPS

Kevork Boyadjian, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average

High performer (top quartile)
MIPS Final Score
96.4/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Internal Medicine Physician) - 96.4/100 vs national avg 83.1

0%100%National avg83%96.4%
MIPS final score (Internal Medicine Physician) - 96.4/100 vs national avg 83.1
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Kevork Boyadjian, MD appears in the CMS NPPES registry as an Internal Medicine Physician provider holding MD credentials at 7506 ELIOT AVE, Middle Village, NY, 11379, with a listed phone of (718) 639-4258. NPI 1316054539 was issued on 08/24/2006.

Medicare Part D records for calendar year 2023 show 8,337 prescription claims written by this provider, covering 475 Medicare beneficiaries and totaling roughly $786K in drug spend, split 17% brand-name and 82% generic by claim count, with an opioid prescribing rate of 0.5%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 96.4/100 for the 2023 performance year (Quality 97.8, Cost 73.1), compared with the national average of 83.1.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,737 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7506 ELIOT AVE
Middle Village, NY 11379

Provider Details

NPI 1316054539
Specialty Internal Medicine Physician
Credentials MD
Gender Male
NPI Issued 08/24/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

96.3517
Final Score
Avg: 83.1
97.7567
Quality
73.1387
Cost

Reporting: Individual

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Kevork Boyadjian, MD. Source: openpaymentsdata.cms.gov.

Total received

$372

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - New York NYSBPMC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Kevork Boyadjian, MD. To verify Kevork Boyadjian, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

Kevork Boyadjian, MD - brand share 17.0%
Internal Medicine Physician average

17% brand-name claims vs 82% generic, on 8,337 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

8,337
Total Claims
$786K
Total Drug Cost
475
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
14,489
Total Day Supply
403,490
Brand vs Generic
17% brand / 82% generic
Brand Drug Cost
$631K
Generic Drug Cost
$152K
Opioid Claims
42 (0.5% rate)
Antibiotic Claims
165

Patient Demographics

Average Patient Age
81.6 years
Avg HCC Risk Score
1.53
Gender Split
63% female / 37% male
Age Distribution
<65: 11, 65-74: 92, 75-84: 180, 85+: 192

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Kevork Boyadjian, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Amlodipine Besylate
539
Atorvastatin Calcium
532
Levothyroxine Sodium
473
Eliquis
Apixaban
361
Metoprolol Succinate
326
Furosemide
267
Mirtazapine
241
Lisinopril
232
Metformin Hcl
199
Losartan Potassium
184

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How Kevork Boyadjian, MD fits within the Internal Medicine Physician landscape nationally.

172,737
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

Kevork Boyadjian, MD's 8,337 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Boyadjian.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Internal Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Kevork Boyadjian, MD's specialty?
Kevork Boyadjian, MD specializes in Internal Medicine Physician and practices in Middle Village, New York. Credentials: MD.
How much does Kevork Boyadjian, MD prescribe under Medicare Part D?
In 2023, Kevork Boyadjian, MD wrote 8,337 Medicare Part D claims totaling $786K in drug costs for 475 beneficiaries.
What is Kevork Boyadjian, MD's Medicare quality score?
Kevork Boyadjian, MD has a CMS MIPS Final Score of 96.4/100 (Quality: 97.8, Cost: 73.1). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Kevork Boyadjian, MD located?
Kevork Boyadjian, MD is located at 7506 ELIOT AVE, Middle Village, NY, 11379. Phone: (718) 639-4258.
What is Kevork Boyadjian, MD's NPI number?
Kevork Boyadjian, MD's National Provider Identifier (NPI) is 1316054539, issued on 08/24/2006.
Does Kevork Boyadjian, MD prescribe more brand-name or generic drugs?
Kevork Boyadjian, MD's prescribing is 17% brand-name and 82% generic drugs by claim count, with $631K in brand drug costs.
Does Kevork Boyadjian, MD prescribe opioids?
Yes, Kevork Boyadjian, MD had 42 opioid claims in 2023 with an opioid prescribing rate of 0.5%.
How many Internal Medicine Physician providers are there in the US?
There are 172,737 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does Kevork Boyadjian, MD prescribe most often?
Based on 2023 Medicare Part D data, Kevork Boyadjian, MD's most frequently prescribed drugs include Amlodipine Besylate, Atorvastatin Calcium, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Kevork Boyadjian, MD accept Medicare?
Kevork Boyadjian, MD appears in CMS Medicare data with 8,337 Part D claims and 475 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Kevork Boyadjian, MD's credentials?
Kevork Boyadjian, MD's NPI is 1316054539 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the editorial process.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.